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Abstract
Severe maternal thyroid dysfunction during pregnancy affects fetal brain growth and corticogenesis. This study focused on the
effect of maternal hypothyroxinemia during early pregnancy on growth of the fetal and infant head. In a population-based birth
cohort, we assessed thyroid status in early pregnancy (median 13.4, 90% range 10.8-17.2), in 4894 women, and measured the
prenatal and postnatal head size of their children at 5 time points. Hypothyroxinemia was defined as normal thyroid-
stimulating hormone levels and free thyroxine-4 concentrations below the 10th percentile. Statistical analysis was performed
using linear generalized estimating equation. Maternal hypothyroxinemia was associated with larger fetal and infant head size
(overall estimate b: 1.38, 95% confidence interval 0.56; 2.19, P ¼ .001). In conclusion, in the general population, even small varia-
tions in maternal thyroid function during pregnancy may affect the developing head of the young child.
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Introduction
Thyroid hormones are important for different developing organ
systems such as the kidney, lung, and skeleton. Furthermore,
thyroid hormones play a crucial role, particularly in fetal brain
maturation.1 As supported by experimental data in animals, a
shortage of maternal thyroid hormones impacts the cytoarchi-
tecture and radial distribution of specific neurons in the somo-
tosensory cortex and hippocampus of the fetus.2,3 Other studies
have suggested a detrimental effect of maternal thyroid dys-
function in pregnancy on the cognitive and behavioral develop-
ment of the child.4 Recently, we found that a low maternal free
thyroxine-4 (FT4) concentration in early pregnancy predicts
the cognitive delay in children.5
It has been shown that children with congenital hypothyr-
oidism have larger head circumferences.6-9 Newborns of
hypothyroid mothers are reported to have a smaller head cir-
cumference and lower birth weight.10 Impaired prenatal brain
development, as indexed by fetal head growth may underlie
this association. The consequences of subtle nonclinical varia-
tions in the maternal thyroid status during pregnancy on fetal
1 The Generation R Study Group, Erasmus MC, University Medical Center
Rotterdam, Rotterdam, Netherlands
2 Department of Child and Adolescent Psychiatry/Psychology, Erasmus MC,
University Medical Center Rotterdam, Rotterdam, Netherlands
3 Department of Obstetrics & Gynecology, Erasmus MC, University Medical
Center Rotterdam, Rotterdam, Netherlands
4 Department of Epidemiology, Erasmus MC, University Medical Center Rot-
terdam, Rotterdam, Netherlands
5 Department of Clinical Genetics, Erasmus MC, University Medical Center
Rotterdam, Rotterdam, Netherlands
6 Department of Endocrinology, Erasmus MC, University Medical Center
Rotterdam, Rotterdam, Netherlands
7 Department of Paediatrics, Erasmus MC, University Medical Center Rot-
terdam, Rotterdam, Netherlands
8 Department of Internal Medicine, Erasmus MC, University Medical Center
Rotterdam, Rotterdam, Netherlands
9 Clinical Chemistry, Erasmus MC, University Medical Center Rotterdam,
Rotterdam, Netherlands
10 Department of Psychiatry, Erasmus MC, University Medical Center Rot-
terdam, Rotterdam, Netherlands
Corresponding Author:
Henning Tiemeier, Department of Child and Adolescent Psychiatry, Erasmus
Medical Center, Sophia Children’s Hospital, University Medical Center Rot-
terdam, P.O. Box 2060, 3000 CB Rotterdam, Netherlands
Email: h.tiemeier@erasmusmc.nl
Reproductive Sciences
19(12) 1315-1322
ª The Author(s) 2012
Reprints and permission:
sagepub.com/journalsPermissions.nav
DOI: 10.1177/1933719112450338
http://rs.sagepub.com
head and brain development, however, are not clear. Moreover,
birth outcomes such as birth weight or head circumference at
birth are only crude summary measures of intrauterine growth
and cannot provide information of the growth across different
time periods in pregnancy. Neonates can reach the same birth
weight by different fetal growth trajectories.11 Studies that
investigate the influence of maternal thyroid status on fetal
head growth during pregnancy are scarce.12
Therefore, in the current study, we investigated whether
maternal thyroid status assessed in early pregnancy is related
to prenatal and postnatal head growth. We also explored
whether any effect on the growth trajectories of the fetal head
mediates the association between maternal thyroid function
and postnatal cognitive infant development.
Materials and Methods
Design and Study Population
This study was embedded in the Generation R Study, an
ongoing population-based birth cohort from fetal life onward.
The Generation R Study, designed to identify early environ-
mental and genetic determinants of growth, development and
health, has been previously described in detail.13 Assessments
were performed with ultrasonography, physical examinations,
biological samples, and detailed questionnaires.
In mothers of 5831 fetuses, thyroid-stimulating hormone
(TSH) and FT4 concentrations were measured during early
pregnancy. Twin pregnancies (n ¼ 124) were excluded since
maternal thyroid function and growth potentials for individual
fetuses in multiple pregnancies are different from singleton
pregnancies. We excluded pregnancies of mothers receiving
any thyroid-related medication including thyroxin (n ¼ 39)
leaving 5276 children. Totally, 392 mothers participated with
2 or 3 siblings. Since the results did not differ after random
exclusion of 1 or 2 of the siblings, they were included in the
analyses. We excluded 256 mothers with thyroid problems
other than hypothyroxinemia. Of the remainder, 4638 mothers
had at least 1 prenatal or postnatal measurement of head cir-
cumference and were included in one or more analyses.
The study has been approved by the Medical Ethics Com-
mittee of the Erasmus Medical Center, Rotterdam. Written
informed consent was obtained from all participants before
participation.
Assessment of Maternal Thyroid Function and
Urinary Iodine
In early pregnancy (median 13.4, 90% range 10.8-17.2),
venous blood samples were drawn in plain tubes. Subsequently,
serum was transported to the regional laboratory for storage at
80C within 3 hours after sampling.14 Maternal TSH and FT4
from the stored samples were assayed in batches of 50 to 150
over a 6-month period using a chemoluminescence assay on the
Vitros ECI Immunodiagnostic System (ORTHO Clinical Diag-
nostics, Rochester, New York). The interassay coefficients of
variation (CVs) for TSH and FT4 were <4.1% and <5.4%,
respectively, whereas the intraassay CVs were <1.2% and
<2.7%, respectively. Thyroid peroxidase (TPO) antibodies are
measured using ImmunoCAP 250-assays (Phadia AB, Uppsala,
Sweden). Maternal TPO-antibodies was measured using the
Phadia 250 immunoassay (Phadia AB) and regarded as positive
when >60 IU/mL.
Reference ranges for maternal TSH (0.03-4.56 mIU/L), FT4
(10.36-22.16 pmol/L) levels were defined as the range between
the 2.5th and 97.5th percentiles, after exclusion of women with
known thyroid disease, thyroid-related medication usage, and
twin pregnancies. Hypothyroxinemia was defined as normal
TSH levels and FT4 concentrations below the 10th percentile
(11.82 pmol/L). This definition has been applied to the current
sample before.5
Maternal subclinical hypothyroidism (TSH >97.5% and FT4
>2.5%; n ¼ 31), overt hypothyroidism (TSH >97.5% and FT4
<2.5%; n ¼ 5), and hyperthyroidism (TSH<2.5% and
FT4>97.5%; n¼ 14) were not studied as determinant due to the
small number of children at risk.
At the same time of blood sampling, maternal single voided
urine samples were collected at random moments over the day.
In a subsample of 1082 women, urinary iodine was measured
through the ceri-arsenite reaction following destruction by
means of ammoniumpersulfate. After brief centrifugation,
sodium arsenite solution (0.1 mol/L in 1 mol/L of sulfuric
acid) was added. Subsequently, ceriammonium sulfate was
added and color was allowed to develop at 250C during 60
minutes. Optical density was assessed at 405 nm. At a level
of 1.7 mmol/L the within-assay CV was 5.1% and the
between-assay CV was 14.3%.
To adjust for total urinary volume, we used the iodine to
creatinine ratio.
Fetal Ultrasound Examinations and Postnatal
Assessments
Sonographers carried out fetal ultrasound examinations at the
visits to the research centers in early, mid, and late pregnancy.
Most assessments (88%) were performed at the Generation R
research center in Rotterdam. The remaining assessments were
carried out in 1 of 5 collaborating hospitals. The fetal ultra-
sound examinations were used to establish gestational age and
to assess the fetal growth characteristics. Crown-rump length
was used for pregnancy dating until a gestational age of 12
weeks. The measurement of the biparietal diameter in the first
trimester was used for pregnancy dating after 12 weeks.
The median (90% range) gestational age for the fetal ultra-
sound examinations in early, mid, and late pregnancy was 13.4
(10.8-17.2) weeks, 20.5 (19.1-22.6) weeks, and 30.3 (29.0-
32.2) weeks, respectively. Postnatal measurement in early and
mid-infancy was performed at 2.1 (1.0-3.8) and 6.3 (5.5-11.3)
months of infant age, respectively.
To control for possible symmetric growth restriction, we
corrected for abdominal circumference in additional analyses.
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Measurements used for the present study, including head
circumference and abdominal circumference, were performed
using standardized techniques. The head circumference was
measured at the level of the biparietal diameter and represents
the outer perimeter of the fetal skull. Sonographers were
blinded to the thyroid status of the pregnant women.
The intraobserver and interobserver reliability of fetal bio-
metry measurements in early pregnancy within the Generation
R Study is good (intraclass correlation coefficients for head cir-
cumference 0.995 [intraobserver] and 0.988 [interobserver] and
for biparietal diameter 0.995 [intraobserver] and 0.994 [inter-
observer] with CVs between 1.8% and 3.8%).15
Postnatal measurements of child head circumference were
collected at community health centers as part of routine health
care using standardised procedures of health centers in the
Netherlands.16
Cognitive Assessment
Parent Report of Children Abilities (PARCA) was used as an
indicator of cognitive development. The PARCA compromises
48 parent-reported items on the ability of their children to per-
form specific nonverbal cognitive tasks at age 30 months. A
delay was defined as nonverbal cognitive scores below the
15th age- and gender-specific percentile. Previously, we
showed a consistent association of maternal hypothyroxinemia
with delayed cognitive functioning.11
Covariates
Information on maternal age, parity, national origin, education,
prenatal smoking and alcohol use, folic acid use, and prenatal
psychological problems was obtained by questionnaires during
pregnancy. Educational level of the mother was assessed by the
highest completed education and reclassified into 3 categories:
primary school, secondary school, and higher education.
National origin of the mother was based on the country of birth
of the parents. Maternal prenatal smoking and alcohol use were
classified as ‘‘no use,’’ ‘‘use until pregnancy was confirmed,’’
and ‘‘continued use during pregnancy.’’ Height and weight were
measured without shoes and heavy clothing; body mass index
(BMI) was calculated from height and weight (weight/height2).
At 20 weeks of pregnancy, we measured maternal prenatal psy-
chological problems using the Brief Symptom Inventory.13
Child’s gender, birth weight, Apgar scores 1 minute after birth,
and the mode of delivery were derived from medical records
completed by gynecologists and midwives. To define the gesta-
tional age at birth, we used the last menstrual period of the
mother and the ultrasound examination at the first prenatal visit.
Statistical Analysis
Maternal thyroid status was a categorical determinant in our
analyses. First, to examine the associations between maternal
thyroid status during early pregnancy and fetal or infant head
size at different ages, linear regression models (ANOVA) were
used. To enable comparison, these analyses were restricted to
children with all 3 prenatal ultrasounds and 2 postnatal mea-
surements of mothers with hypothyroxinemia of reference thyr-
oid status (n ¼ 2621).
Linear generalized estimating equation (GEE) analyses14
were used to study the longitudinal effects of maternal hypothyr-
oxinemia on fetal and child head size in all 4638 children. With
GEE analyses, repeatedly measured head size were analyzed
over time, taking correlations within the same participant into
account. We calculated the overall effect of maternal hypothyr-
oxinemia on head size throughout the longitudinal period.
Additionally, to test a dose–response relation with head
growth in the lower tail of the FT4 distribution, P for trends
were calculated. Aimed on this, hypothyroxinemia was divided
in 2 categories: FT4 levels within the 5th to 10th percentile and
FT4 <5th percentile.
All analyses were adjusted for maternal age, BMI, parity,
education, national origin, smoking, alcohol use, prenatal psy-
chological problems, child’s gender, intrauterine position, and
gestational age at ultrasound measurement. For postnatal anal-
yses, age at birth and birth weight were also added as confoun-
ders to the model. The choice of potential confounders was
determined a priori based on earlier literature.17,18 Further cov-
ariates were included in the analyses if the effect estimates of
maternal thyroid function changed (5%). Pregnancy compli-
cations and birth weight did not pass this threshold.
Furthermore, we explored whether the fetal head growth
mediated any observed association between thyroid status and
cognitive delay.Aimed on this,we first testedwhether the thyroid
status increased the riskof cognitivedelay in the current sample of
children. Next, we used linear regression models (ANOVA) to
study if head circumference during pregnancy is related to non-
verbal cognitive functioning. Finally, we tested possible media-
tion by studying the effect estimate change if head size is added
to the model of thyroid status and cognitive delay.
Results
Characteristics of pregnant women and their children categor-
ized by thyroid status are presented in Table 1. Based on the cri-
teria described above, 476 (9.7%) mothers had
hypothyroxinemia. Hypothyroxinemic women are older, less
educated, more often of non-Dutch national origin, and more
often smoking in pregnancy. Urinary iodine concentration did
not differ among hypothyroxinemic and nonhypothyroxinemic
mothers. Children born to women with hypothyroxinemia have
higher birth weight.
Table 2 presents the association between hypothyroxinemia
and fetal head size by gestational age. In early pregnancy, head
circumference of fetuses of hypothyroxinemic mothers was
0.7 mm (95% confidence interval [CI] 0.2-1.2) larger as com-
pared to the reference group (89.6 mm; 95% CI 89.4-89.7, P ¼
.008). Later in pregnancy, there were no significant differences
in fetal head circumference.
Postnatal children born to hypothyroxinemic mothers had
larger head circumference compared to mothers with reference
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thyroid status (2.4 mm; 95% CI 1.0-3.8, P ¼ .001 in early
infancy and 2.0 mm; 95% CI 0.4-3.5, P ¼ .01 in mid-infancy).
The GEE analysis, which summarizes the effect over time,
showed a significant increased head size over time in children
born to hypothyroxinemic mothers as compared to mothers
with reference thyroid status (b: 1.38, 95% CI 0.56-2.19,
P ¼ .001).
Figure 1 depicted the associations between hypothyroxine-
mia and head size at individual time points and during
follow-up. The figure suggests that the effect of hypothyroxine-
mia on head size differs over time. Significant effects for
individual time points in early pregnancy and infancy were
observed, however, the differences between time points were
not significant; indeed, the GEE model did not show any time
differences (b .64, 95% CI 1.52-0.24, P ¼ .16).
To distinguish between decreased head growth and a more
general symmetrical growth restriction including decreased
head circumference, we additionally adjusted for abdominal
circumference measured at the same gestational age. The effect
of hypothyroxinemia on fetal head circumference remained
present (difference in head circumference for hypothyroxine-
mia early in pregnancy 0.7 mm, 95% CI 0.2-1.2, P ¼ .01).
Table 2. Fetal and Infant Head Size Stratified by Maternal Thyroid Status During Pregnancya
Fetal and Infant Head Size in mm Stratified by Maternal Thyroid Status, N ¼ 2621
Fetal head circumference Early pregnancy,
median 13.4 weeks
Mid-pregnancy,
median 20.5 weeks
Late pregnancy,
median 30.3 weeks
Reference, mm (95% CI) 89.6 (89.4-89.7) 178.9 (178.7-179.2) 285.3 (284.9-285.6)
Hypothyroxinemia, mm (95% CI) 90.3 (89.8-90.8) 179.1 (178.4-179.9) 286.1 (285.1-287.2)
P value for adjusted difference .008 .60 .14
Infant head circumference Early infancy, median 2.1 months Mid-infancy, median 6.3 months
Reference, mm (95% CI) 391.9 (391.5-392.4) 438.9 (438.4-439.9)
Hypothyroxinemia, mm (95% CI) 394.3 (393.0-395.6) 440.9 (439.4-442.3)
P value for adjusted difference .001 .01
Abbreviation: CI, confidence interval.
a Values are obtained from linear regression models (ANOVA). Adjusted for maternal age, BMI, height, educational level, national origin, parity, smoking, alcohol
use and maternal psychopathology and fetal intra uterine position and gender. Prenatal analyses are adjusted for gestational age at assessment based on ultrasound;
postnatal analyses are adjusted for infant age at assessment. Postnatal analyses are also adjusted for gestational age at birth.
Table 1. Study Population by Maternal Thyroid Status (Total n ¼ 4638)a
Thyroid Status Reference, n ¼ 4162 Hypothyroxinemia, n ¼ 476 P Value
Maternal characteristics
Gestational age intake, wks median (90% range) 13.2 (10.1-17.5) 14.8 (10.9-17.8) <.001
Age, yrs, mean (SD) 29.7 (5.0) 30.2 (5.1) .09
Parity (nulliparous %) 58.4 51.0 <.001
Body mass index, kg/m2 24.3 (4.3) 26.1 (4.7) <.001
Educational level, % <.001
Primary level 4.6 7.4
Secondary level 41.4 48.8
Higher education 53.9 43.8
National origin, % <.001
Dutch 55.0 42.5
Other Western 12.2 12.1
Non-Western 32.8 45.4
Smoking in pregnancy, % .50
No 72.5 66.9
Yes, stopped 8.6 9.8
Yes, continued 18.9 23.3
Iodine concentration, mg/mg creatinine median (90% range) 272 (112-619) 296 (105-731) .90
<10th percentile (%) 10.0 8.8 .70
Child characteristics
Gender (% boys) 51.4 50.4 .67
Gestational age birth, wks, mean (SD) 39.9 (1.8) 39.8 (2.2) .66
Birth weight, g, mean (SD) 3411.4 (557.9) 3499.9 (562.6) .001
Abbreviation: SD, standard deviation.
a Maternal characteristics were assessed at intake. Child characteristics were assessed at birth. Values represent percentage (%) within column, mean (SD), or
median (90% range). Independent Students t test, Mann-Whitney U, and chi-square tested for differences in baseline.
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Next, we explored whether the effect of hypothyroxinemia
was dose responsive. There was a dose–response relation in the
lower range of the FT4 distribution between the degree of
hypothyroxinemia and fetal head growth in early pregnancy (b
for linear contrast 0.64, 95% CI 0.14-1.13, P for trend ¼ .01).
Finally, we tested whether head size early in pregnancy
mediated the relation between maternal thyroid status and cog-
nitive delay. In the current sample, hypothyroxinemia was
associated with an increased risk of cognitive delay (odds ratio
[OR] ¼ 1.63, 95% CI 1.06-2.52, P ¼ .03). Head circumference
measured during early pregnancy showed no association with
cognitive delay (b 0.007, 95% CI 0.04-0.03, P ¼ .99).
This means that children with larger heads, early in preg-
nancy, did not have a higher risk of cognitive delay. The rela-
tion between thyroid status and cognitive delay can thus not
be explained by early fetal head size. Using continuous mea-
sures of cognitive delay or curvilinear models of head size did
not provide any evidence for mediation by fetal head size
either (data not shown).
Discussion
In our study, maternal hypothyroxinemia in early pregnancy
was associated with a larger size of the fetal and infant head.
In early pregnancy, the effect was dose–response; severe
hypothyroxinemia was associated with more severe deviations
in head growth than mild hypothyroxinemia.
The growth of the fetal head did not primarily differ due to
fetal dating differences in early pregnancy. In principle, the
observed effects could reflect differences in fetal dating in
early pregnancy. This seems unlikely since both sonographers
and patients were blinded to thyroid status and hypothyroxine-
mia is an asymptomatic condition. The observed growth differ-
ence showed a consistent dose–response pattern in early
pregnancy and the difference in head size continued after birth.
In our study, hypothyroxinemia was not due to lower iodine
concentrations suggesting that thyroid problems in this iodine
sufficient area mostly have other origins. However, iodine
excretion was measured only in a subsample.
Different explanations may help to understand the untoward
effects of low FT4 levels in pregnancy on prenatal and postna-
tal head growth.
First, fetal growth may be impaired by low FT4 levels that
affect placentation in early pregnancy. This is supported by the
associations between maternal thyroid dysfunction and preg-
nancy complications related to malplacentation, including pre-
eclampsia, intrauterine growth retardation, and still birth. It has
been suggested that uteroplacental tissues are sensitive to
minor perturbations in maternal thyroid function.19 A relation
between placental insufficiency and a smaller head size in
childhood with increasing divergence after puberty has been
reported.20 On the other hand, our study also showed reduced
growth of the fetal head circumference, even after controlling
for the effects of low maternal FT4 levels on abdominal cir-
cumference. This indicates that thyroid hormones have a differ-
ential effect of on fetal head size.
A second explanation for the effect of the prenatal maternal
hypothyroxinemia is the direct effect of thyroid hormones on
Figure 1. Estimated differences in head circumference in fetuses or infants of mothers with hypothyroxinemia compared with the reference
group as obtained from linear regression models. Generalized estimating equation (GEE) analysis was used to calculate the overall estimate. All
models were adjusted for maternal age, body mass index (BMI), height, educational level, national origin, parity, folic acid supplement use, smok-
ing, alcohol use and maternal psychological symptoms and child gender, intrauterine position, and (gestational) age at assessment. Postnatal and
longitudinal analyses were also adjusted for gestational age at birth.
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the developing brain. Such a mechanism has mainly been shown
in animal studies.Auso´ et al reported that FT4 deficits in rats alter
normal migration of cortical neurons and the cytoarchitectonic
organization of the neocortex and hippocampus in the offspring.2
If we infer the critical period from animal studies, the human fetal
brain should bemost vulnerable tomaternal hypothyroxinemia in
late first trimester or midgestation. In that period, neurogenesis,
myelination, and apoptosis take place that might explain the
observed differences in size in early pregnancy.21,22 Around birth
synaptogenesis starts and the number of synapses growths expo-
nential till the first year of life.23 Synaptogenesis starts to acceler-
ate at the beginning of the third trimester of pregnancy and
increases rapidly in the first 2 years of life. However, we argue
as no statistically significant differences were observed between
time points this interpretation is very speculative.
Apoptosis is important for normal brain development as
20% to 50% of neurons are known to undergo programmed cell
death.24 In rats, neonatal administration of thyroxin produces
smaller cerebellum with fewer folia.21,22 Studies on the in vivo
effects of thyroid hormone upon neurons of the cerebral cortex
show that thyroid hormone produces an increase of protea-
some–ubiquitin–protein conjugates and an increase in apopto-
sis.25,26 This implies that a decrease in thyroxin need not lead to
a decrease in brain tissue.
Third, as animal studies have shown, maternal thyroid hor-
mones may affect fetal programming by epigenetic mechan-
isms in the structures and functions of organs. This is
substantiated by studies showing acute changes in the maternal
thyroid hormones that directly affect the expression of selected
and stage-specific genes in the fetal brain.27,28 A decrease in T4
resulted in less expression of neuroendocrine-specific protein.
This protein inhibits axonal growth action of central myelin
in growth cone collapse and neurite outgrowth29 that probably
results in increased brain mass. Again, this is in line with our
observation that lower thyroid levels in early life are associated
with a larger head circumference.
A fourth explanation for our observation might be that a lack
of thyrotropin caused abnormal skull development, and
abnormalities in thyrotropin metabolism are known to affect
the skeletal development. However, the described delay in ossi-
fication and reduction of bone mineralization typically
decrease rather than increase growth velocity.30 Furthermore,
experimental work has shown that the growth of the vault of the
skull depends on and is controlled by the growth of the brain.31
As head circumference is known to correlate to brain vol-
ume, it is tempting to speculate that increased head growth is
one of the mediators in the relationship between maternal thyr-
oid status in pregnancy and psychological and behavioral child
development.32 However, children with autism spectrum disor-
ders also show increased growth in head circumference during
postnatal life. While there are probably some differences in the
brain growth trajectories between these 2 conditions (ie, the
exact onset of altered head growth in children with autism,33
it is tempting to speculate that related neurobiological mechan-
isms, such as the postnatal acceleration of formation of cortical
neurones,34,35 underlie both conditions.
Besides, data from the present cohort showed that maternal
hypothyroxinemia negatively affected behavior and cognitive
functioning in infants.5,36 Inverted U-shaped associations
between mid and late pregnancy head size and infant alertness
have been reported previously indicating that both smaller and
larger heads are negatively associated with this indicator of
early neurobehavioral development.37 However, here we found
no indication that a larger head in the first trimester is related to
cognitive functioning. Possibly, structural changes not
expressed by changes in head size may underlie this cognitive
delay. Alternatively, a large head can reflect healthy and unto-
ward effects, and this covers the negative impact of maternal
thyroid status. Second, a catch-up and compensatory effect of
brain development may make any early pregnancy effect not
observable in toddlers anymore.
The strengths of this present study include our combination
of ultrasound and postnatal measurements, which enabled us to
determine the growth trajectories throughout gestation and
infancy.
The large population-based prospective cohort enabled us to
control for important confounding factors, including lifestyle
factors, socioeconomic factors, and known determinants of
fetal and infants’ growth. Despite this, it cannot be ruled out
that the associations are confounded by diet-related determi-
nants or other unknown factors. Unfortunately, postnatal head
circumference was not measured routinely at the Dutch child
health care centres after the first year anymore. Longer
follow-up studies are necessary to determine whether maternal
hypothyroxinemia affects child head growth later in life.
Finally, since data were more complete in higher-educated
mothers, we cannot rule out that selective nonresponse influ-
enced our findings.
In conclusion, in the general population, even small varia-
tions in maternal thyroid function during pregnancy may affect
the developing head of the young child.
Low maternal FT4 increases the head circumference in the
first trimester of pregnancy and in early infancy. However, the
effect of altered head growth on cognitive functioning is not yet
clear. Further studies of the possible effect of screening and
intervention based on maternal thyroid function are needed.
Acknowledgments
The Generation R Study is conducted by the Erasmus Medical Center
Rotterdam in close collaboration with the Faculty of Social Sciences
of the Erasmus University Rotterdam, the Municipal Health Service
Rotterdam area, the Rotterdam Homecare Foundation and the Sticht-
ing Trombosedienst & Artsenlaboratorium Rijnmond (STAR), Rotter-
dam. We gratefully acknowledge the contribution of all participants,
general practitioners, hospitals, midwives, and pharmacies in Rotter-
dam. We would like to acknowledge Mrs T. White, MD, PhD, for her
insightful suggestions.
Declaration of Conflicting Interests
The authors declared no potential conflicts of interest with respect to
the research, authorship, and/or publication of this article.
1320 Reproductive Sciences 19(12)
Funding
The authors disclosed receipt of the following financial support
for the research, authorship, and/or publication of this article: the
general design of the Generation R Study was made possible by
financial support from the Erasmus Medical Center, Rotterdam; the
Erasmus University Rotterdam; the Dutch Ministry of Health, Wel-
fare and Sport; and the Netherlands Organization for Health
Research and Development (ZonMw). The current study was sup-
ported by a grant from ZonMw (grant no. 10.000.1003) and a
research grant from the European Community’s 7th Framework Pro-
gramme (FP7/2008–2013) under grant agreement 212652 (NUTRI-
MENTHE project, ‘‘The Effect of Diet on the Mental Performance
of Children’’). NM was supported by an additional grant from the
Sophia Foundation for Medical Research (SSWO grant number
268). The work of HT was supported by a NWO-ZonMW VIDI grant
(grant no. 017.106.370).
References
1. Kester MH, Martinez de Mena R, Obregon MJ, et al. Iodothyro-
nine levels in the human developing brain: major regulatory roles
of iodothyronine deiodinases in different areas. J Clin Endocrinol
Metab. 2004;89(7):3117-3128.
2. Auso E, Lavado-Autric R, Cuevas E, Del Rey FE, Morreale De
Escobar G, Berbel P. A moderate and transient deficiency of
maternal thyroid function at the beginning of fetal neocorticogen-
esis alters neuronal migration. Endocrinology. 2004;145(9):
4037-4047.
3. de Escobar GM, Ares S, Berbel P, Obregon MJ, del Rey FE. The
changing role of maternal thyroid hormone in fetal brain develop-
ment. Semin Perinatol. 2008;32(6):380-386.
4. Pop VJ, Brouwers EP, Vader HL, Vulsma T, van Baar AL, de
Vijlder JJ. Maternal hypothyroxinaemia during early pregnancy
and subsequent child development: a 3-year follow-up study. Clin
Endocrinol (Oxf). 2003;59(3):282-288.
5. Henrichs J, Bongers-Schokking JJ, Schenk JJ, et al. Maternal
thyroid function during early pregnancy and cognitive function-
ing in early childhood: the generation R study. J Clin Endocrinol
Metab. 2010;95(9):4227-4234.
6. Ng SM,Wong SC, Didi M. Head circumference and linear growth
during the first 3 years in treated congenital hypothyroidism in
relation to aetiology and initial biochemical severity. Clin Endo-
crinol (Oxf). 2004;61(1):155-159.
7. Burt L, Kulin HE. Head circumference in children with short sta-
ture secondary to primary hypothyroidism. Pediatrics. 1977;
59(4):628-630.
8. Bucher H, Prader A, Illig R. Head circumference, height, bone
age and weight in 103 children with congenital hypothyroidism
before and during thyroid hormone replacement. Helv Paediatr
Acta. 1985;40(4):305-316.
9. Grant DB. Growth in early treated congenital hypothyroidism.
Arch Dis Child. 1994;70(6):464-458.
10. Blazer S, Moreh-Waterman Y, Miller-Lotan R, Tamir A, Hoch-
berg Z. Maternal hypothyroidism may affect fetal growth and
neonatal thyroid function. Obstet Gynecol. 2003;102(2):232-241.
11. Bloomfield FH, Oliver MH, Harding JE. The late effects of fetal
growth patterns. Arch Dis Child Fetal Neonatal Ed. 2006;91(4):
F299-F304.
12. Shields BM, Knight BA, Hill A, Hattersley AT, Vaidya B. Fetal
thyroid hormone level at birth is associated with fetal growth.
J Clin Endocrinol Metab. 2011;96(6):E934-E938.
13. De Beurs E. Brief Symptom Inventory, handleiding [Dutch man-
ual]. Leiden, The Netherlands; 2004.
14. Diggle PJ, Liang KY, Zeger SL. Analysis of Longitudinal Data.
Oxford, England: Oxford University Press; 2000.
15. Verburg BO, Mulder PG, Hofman A, Jaddoe VW, Witteman JC,
Steegers EA. Intra- and interobserver reproducibility study of
early fetal growth parameters. Prenat Diagn. 2008;28(4):
323-331.
16. Jaddoe VW, van Duijn CM, van der Heijden AJ, et al. The Gen-
eration R Study: design and cohort update 2010. Eur J Epidemiol.
2010;25(11):823-841.
17. Kramer MS. Intrauterine growth and gestational duration determi-
nants. Pediatrics. 1987;80(4):502-511.
18. Mook-Kanamori DO, Steegers EA, Eilers PH, Raat H, Hofman
A, Jaddoe VW. Risk factors and outcomes associated with
first-trimester fetal growth restriction. JAMA. 2010;303(6):
527-534.
19. Cleary-Goldman J, Malone FD, Lambert-Messerlian G, et al.
Maternal thyroid hypofunction and pregnancy outcome. Obstet
Gynecol. 2008;112(1):85-92.
20. Pryor J, Silva PA, Brooke M. Growth, development and beha-
viour in adolescents born small-for-gestational-age. J Paediatr
Child Health. 1995;31(5):403-407.
21. Benno R, Desroches D, Hahn M, Salinas J. Brain growth and
behavior in developing Fuller BWS mice: effects of thyroid hor-
mone. Soc Neurosci Abstr. 1985;11:529.
22. Lauder JM, Altman J, Drebs H. Some mechanisms of cerebellar
foliation: effects of early hypo- and hyperthyroidism. Brain Res.
1974;76(1):33-40.
23. Thompson RA, Nelson CA. Developmental science and the
media. Early brain development. Am Psychol. 2001;56(1):5-15.
24. Oppenheim RW. Cell death during development of the nervous
system. Annu Rev Neurosci. 1991;14:453-501.
25. Pasquini LA, Marta CB, Adamo AM, Pasquini JM, Soto EF. Rela-
tionship between the ubiquitin-dependent pathway and apoptosis
in different cells of the central nervous system: effect of thyroid
hormones. Neurochem Res. 2000;25(5):627-635.
26. Marta CB, Adamo AM, Soto EF, Pasquini JM. Sustained neonatal
hyperthyroidism in the rat affects myelination in the central ner-
vous system. J Neurosci Res. 1998;53(2):251-259.
27. Dowling AL, Martz GU, Leonard JL, Zoeller RT. Acute changes
in maternal thyroid hormone induce rapid and transient changes in
gene expression in fetal rat brain. J Neurosci. 2000;20(6):
2255-2265.
28. Darras VM, Van Herck SL, Geysens S, Reyns GE. Involvement of
thyroid hormones in chicken embryonic brain development. Gen
Comp Endocrinol. 2009;163(1-2):58-62.
29. Woolf CJ. No Nogo: now where to go? Neuron. 2003;38(2):
153-156.
30. Bassett JH, Williams AJ, Murphy E, et al. A lack of thyroid hor-
mones rather than excess thyrotropin causes abnormal skeletal
development in hypothyroidism. Mol Endocrinol. 2008;22(2):
501-512.
Mil et al 1321
31. Tanner JM. Foetus Into Man: Physical Growth From Conception
to Maturity. Cambridge, MA: Harvard University Press; 1990.
32. Cooke RW, Lucas A, Yudkin PL, Pryse-Davies J. Head circum-
ference as an index of brain weight in the fetus and newborn.
Early Hum Dev. 1977;1(2):145-149.
33. Courchesne E, Carper R, Akshoomoff N. Evidence of brain over-
growth in the first year of life in autism. JAMA. 2003;290(3):337-344.
34. Courchesne E, Mouton PR, Calhoun ME, et al. Neuron number
and size in prefrontal cortex of children with autism. JAMA.
2011;306(18):2001-2010.
35. Schapiro S. Some physiological, biochemical, and behavioral
consequences of neonatal hormone administration: cortisol and
thyroxine. Gen Comp Endocrinol. 1968;10(2):214-228.
36. Ghassabian A, Bongers-Schokking JJ, Henrichs J, et al. Maternal
thyroid function during pregnancy and behavioral problems in the
offspring: the generation R study. Pediatr Res. 2011;69(5 Pt 1):
454-459.
37. Henrichs J, Schenk JJ, Schmidt HG, et al. Fetal size in mid- and
late pregnancy is related to infant alertness: the generation R
study. Dev Psychobiol. 2009;51(2):119-130.
1322 Reproductive Sciences 19(12)
